A multicenter retrospective study on efficacy and safety of salvage surgery for primary lung cancer
Not Applicable
- Conditions
- primary lung cancer
- Registration Number
- JPRN-UMIN000028741
- Lead Sponsor
- Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient treated as induction therapy intentionally. 2) Patient who underwent resection not for local lesion (other than lung or regional lymph node). 3) Patient who was treated with molecular targeted therapy other than EGFR-TKI or ALK inhibitor as molecular targeted therapy. 4) Patient who withdrew the consent of this study. 5) Patient who was considered inappropriate to this study by attending doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year overall survival rate
- Secondary Outcome Measures
Name Time Method Adverse event, Incidence of complications, Perioperative mortality, 3-year recurrence free survival rate, Median survival time